Abstract:Smart transformable nanocarriers are promising to treat deep-seated diseases but require adaptable diagnostic/imaging potency to reflect the morphology change and therapeutic feedback, yet their design and synthesis remains challenging. Herein, stimuli-responsive polyprodrug nanoparticles (SPNs) are formulated from the co-assembly of negatively charged corona and positively charged polyprodrug cores, exhibiting high loading content of camptothecin (CPT, ∼28.6 wt %) tethered via disulfide linkages in the core. SPNs are sequentially sensitive to tumor acidic condition and elevated reductive milieu in the cytosol for deep-penetration drug delivery. Upon accumulation at acidic tumor sites, SPNs dissociate to release smaller positively charged polyprodrug nanoparticles, which efficiently enter deep-seated tumor cells to trigger high-dosage parent CPT release in the reductive cytosolic milieu. Meanwhile, the polyprodrug cores of SPNs labeled with DTPA(Gd), a magnetic resonance imaging contrast agent, can trace the cascade degradation and biodistribution of SPNs as well as the resulting intracellular CPT release. The longitudinal relaxivity of SPNs increases stepwise in the above two processes. The size-switchable polyprodrug nanoparticles exhibit remarkable tumor penetration and noteworthy tumor inhibition in vitro and in vivo, which are promising for endogenously activated precision diagnostics and therapy.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c16110?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c16110</a>.Details of synthetic routes, 1H NMR analysis, FT-IR analysis, absorption spectra, TEM analysis, DLS characterization, in vitro drug release, cellular MR imaging, CLSM imaging, in vitro cell viability, flow cytometry analysis, blood circulation profile, in vivo fluorescence imaging, TUNEL staining, H&E-stained images, and hemolysis analysis (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c16110/suppl_file/am0c16110_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Zwitterionic-to-cationic Charge Conversion Polyprodrug Nanomedicine for Enhanced Drug Delivery.

Zein-Paclitaxel Prodrug Nanoparticles for Redox-Triggered Drug Delivery and Enhanced Therapeutic Efficiency.

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

A facile way to fabricate pH-sensitive charge-conversion polymeric nanoparticles with tunable pH conversion point

Development of Zwitterionic Polymer-Based Doxorubicin Conjugates: Tuning the Surface Charge to Prolong the Circulation and Reduce Toxicity.

Transforming a Toxic Drug into an Efficacious Nanomedicine Using a Lipoprodrug Strategy for the Treatment of Patient-Derived Melanoma Xenografts.

Surface charge-reversible polyelectrolyte complex nanoparticles for hepatoma-targeting delivery of doxorubicin.

Polymeric Prodrug by Supramolecular Polymerization

A Ph‐responsive Nanoparticle Delivery System Containing Dihydralazine and Doxorubicin‐based Prodrug for Enhancing Antitumor Efficacy

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Enhanced tumour penetration and prolonged circulation in blood of polyzwitterion–drug conjugates with cell-membrane affinity

Zwitterionic Supramolecular Prodrug Nanoparticles Based on Host-Guest Interactions for Intracellular Drug Delivery

Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy

Enhancing Tumor Penetration and Targeting Using Size-Minimized and Zwitterionic Nanomedicines

Prodrugs Forming High Drug Loading Multifunctional Nanocapsules for Intracellular Cancer Drug Delivery.

Modulating Intracellular Dynamics for Optimized Intracellular Release and Transcytosis Equilibrium

Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy

Biodegradable Phosphorylcholine-Based Zwitterionic Polymer Nanogels with Smart Charge-Conversion Ability for Efficient Inhibition of Tumor Cells.

Stepwise dual pH and redox-responsive cross-linked polypeptide nanoparticles for enhanced cellular uptake and effective cancer therapy.

Ultrafast Charge-Conversional Nanocarrier for Tumor-Acidity-activated Targeted Drug Elivery

Polyprodrug Nanomedicines: an Emerging Paradigm for Cancer Therapy